Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
<h4>Introduction</h4>Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and β2-glycoprotein I (aβ2GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0156407 |
id |
doaj-610c03ee801d4a47896de6c2bb669115 |
---|---|
record_format |
Article |
spelling |
doaj-610c03ee801d4a47896de6c2bb6691152021-03-04T12:32:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015640710.1371/journal.pone.0156407Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.Charis PericleousIsabel FerreiraOrietta BorghiFrancesca PregnolatoThomas McDonnellAcely Garza-GarciaPaul DriscollSilvia PierangeliDavid IsenbergYiannis IoannouIan GilesPier Luigi MeroniAnisur Rahman<h4>Introduction</h4>Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and β2-glycoprotein I (aβ2GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the key antigenic epitopes of β2GPI, could add value to these current tests. We performed an observational, multicenter cohort study to evaluate the utility of IgG, IgM and IgA assays to each of CL, β2GPI and DI in APS.<h4>Methods</h4>Serum from 230 patients with APS (n = 111), SLE but not APS (n = 119), and 200 healthy controls were tested for IgG, IgM and IgA aCL, aβ2GPI and aDI activity. Patients with APS were further classified into thrombotic or obstetric APS. Logistic regression and receiver operator characteristic analyses were employed to compare results from the nine different assays.<h4>Results</h4>All assays displayed good specificity for APS; IgG aCL and IgG aβ2GPI assays however, had the highest sensitivity. Testing positive for IgA aβ2GPI resulted in a higher hazard ratio for APS compared to IgM aβ2GPI. Positive IgG, IgM or IgA aDI were all associated with APS, and in subjects positive for aCL and/or aβ2GPI, the presence of aDI raised the hazard ratio for APS by 3-5 fold. IgG aCL, aβ2GPI, aDI and IgA aDI were associated with thrombotic but not obstetric complications in patients with APS.<h4>Conclusion</h4>Measuring IgG aDI and IgA aβ2GPI and aDI may be useful in the management of patients with APS, particularly thrombotic APS.https://doi.org/10.1371/journal.pone.0156407 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Charis Pericleous Isabel Ferreira Orietta Borghi Francesca Pregnolato Thomas McDonnell Acely Garza-Garcia Paul Driscoll Silvia Pierangeli David Isenberg Yiannis Ioannou Ian Giles Pier Luigi Meroni Anisur Rahman |
spellingShingle |
Charis Pericleous Isabel Ferreira Orietta Borghi Francesca Pregnolato Thomas McDonnell Acely Garza-Garcia Paul Driscoll Silvia Pierangeli David Isenberg Yiannis Ioannou Ian Giles Pier Luigi Meroni Anisur Rahman Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. PLoS ONE |
author_facet |
Charis Pericleous Isabel Ferreira Orietta Borghi Francesca Pregnolato Thomas McDonnell Acely Garza-Garcia Paul Driscoll Silvia Pierangeli David Isenberg Yiannis Ioannou Ian Giles Pier Luigi Meroni Anisur Rahman |
author_sort |
Charis Pericleous |
title |
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. |
title_short |
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. |
title_full |
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. |
title_fullStr |
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. |
title_full_unstemmed |
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. |
title_sort |
measuring iga anti-β2-glycoprotein i and igg/iga anti-domain i antibodies adds value to current serological assays for the antiphospholipid syndrome. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
<h4>Introduction</h4>Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and β2-glycoprotein I (aβ2GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the key antigenic epitopes of β2GPI, could add value to these current tests. We performed an observational, multicenter cohort study to evaluate the utility of IgG, IgM and IgA assays to each of CL, β2GPI and DI in APS.<h4>Methods</h4>Serum from 230 patients with APS (n = 111), SLE but not APS (n = 119), and 200 healthy controls were tested for IgG, IgM and IgA aCL, aβ2GPI and aDI activity. Patients with APS were further classified into thrombotic or obstetric APS. Logistic regression and receiver operator characteristic analyses were employed to compare results from the nine different assays.<h4>Results</h4>All assays displayed good specificity for APS; IgG aCL and IgG aβ2GPI assays however, had the highest sensitivity. Testing positive for IgA aβ2GPI resulted in a higher hazard ratio for APS compared to IgM aβ2GPI. Positive IgG, IgM or IgA aDI were all associated with APS, and in subjects positive for aCL and/or aβ2GPI, the presence of aDI raised the hazard ratio for APS by 3-5 fold. IgG aCL, aβ2GPI, aDI and IgA aDI were associated with thrombotic but not obstetric complications in patients with APS.<h4>Conclusion</h4>Measuring IgG aDI and IgA aβ2GPI and aDI may be useful in the management of patients with APS, particularly thrombotic APS. |
url |
https://doi.org/10.1371/journal.pone.0156407 |
work_keys_str_mv |
AT charispericleous measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT isabelferreira measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT oriettaborghi measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT francescapregnolato measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT thomasmcdonnell measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT acelygarzagarcia measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT pauldriscoll measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT silviapierangeli measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT davidisenberg measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT yiannisioannou measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT iangiles measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT pierluigimeroni measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome AT anisurrahman measuringigaantib2glycoproteiniandiggigaantidomainiantibodiesaddsvaluetocurrentserologicalassaysfortheantiphospholipidsyndrome |
_version_ |
1714802262933504000 |